C. A. . Andra, “Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients ”, Narra J, vol. 3, no. 3, p. e409, Dec. 2023.